In the meantime, a similar drug from IDEC Pharmaceuticals (nasdaq: IDPH - news - people ) reached the market.

FORBES: Feeling Corixa's Pain

Rituxan, the cancer drug sold by Genentech and IDEC Pharmaceuticals (nasdaq: IDPH - news - people ), is already being tested for the same disease.

FORBES: Magazine Article

The most successful offspring is Idec Pharmaceuticals (nasdaq: IDPH - news - people ), which, with help from Genentech, developed Rituxan, a monoclonal antibody for non-Hodgkin's lymphoma.

FORBES: Magazine Article